Camurus AB (publ) (STO:CAMX)
525.00
-12.50 (-2.33%)
Apr 28, 2026, 5:29 PM CET
Camurus AB Revenue
In the year 2025, Camurus AB had annual revenue of 2.27B SEK with 21.30% growth. Camurus AB had revenue of 464.46M in the quarter ending December 31, 2025, a decrease of -16.03%.
Revenue
2.27B
Revenue Growth
+21.30%
P/S Ratio
13.85
Revenue / Employee
7.95M
Employees
285
Market Cap
31.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.27B | 397.80M | 21.30% |
| Dec 31, 2024 | 1.87B | 150.73M | 8.78% |
| Dec 31, 2023 | 1.72B | 760.51M | 79.52% |
| Dec 31, 2022 | 956.34M | 355.77M | 59.24% |
| Dec 31, 2021 | 600.57M | 264.57M | 78.74% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioArctic AB | 2.00B |
| Vicore Pharma Holding AB | 3.82M |
| Hansa Biopharma AB | 190.49M |
| Egetis Therapeutics AB | 62.40M |
| Flerie AB | 1.80M |
| Saniona AB | 434.40M |
| BioInvent International AB | 226.50M |
| Genovis AB (publ.) | 129.65M |
Camurus AB News
- 6 months ago - Camurus reports positive topline results for CAM2056, semaglutide monthly depot - PRNewsWire
- 11 months ago - Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients - PRNewsWire
- 11 months ago - Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins - PRNewsWire
- 1 year ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 1 year ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 2 years ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire